These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1283 related items for PubMed ID: 11434876

  • 1. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y.
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [Abstract] [Full Text] [Related]

  • 2. [Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR].
    Li J, Xu L, He K, Guo W, Zhu X, Zheng Y, Xia P.
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):129-32. PubMed ID: 12015032
    [Abstract] [Full Text] [Related]

  • 3. [Modulation of multiple drug resistance by nomegestrol acetate and droloxifene in K562/A02].
    Li J, Xu L, He K.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):288-91. PubMed ID: 11721384
    [Abstract] [Full Text] [Related]

  • 4. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
    Li J, Xu LZ, Yao JJ, Guo WJ, Xia P, Chen Y.
    Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
    [Abstract] [Full Text] [Related]

  • 5. [Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine].
    Cheng YH, Qi J, Xiong DS, Liu JW, Qi SL, Pan B, Yang CZ, Zhu HF.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):164-8. PubMed ID: 16733896
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U, Walther W, Shoemaker RH.
    J Natl Cancer Inst; 1996 Oct 02; 88(19):1383-92. PubMed ID: 8827016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J, Xia M, Liu W, Li L, Yang J, Mei Y, Meng Q, Xie Y.
    Eur J Pharmacol; 2019 Jun 05; 852():231-243. PubMed ID: 30959046
    [Abstract] [Full Text] [Related]

  • 12. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
    Wang F, Jiang X, Yang DC, Elliott RL, Head JF.
    Anticancer Res; 2000 Jun 05; 20(2A):799-808. PubMed ID: 10810357
    [Abstract] [Full Text] [Related]

  • 13. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L, Durán GE, Chen KG, Dumontet C, Sikic BI.
    J Natl Cancer Inst; 1995 Nov 01; 87(21):1593-602. PubMed ID: 7563202
    [Abstract] [Full Text] [Related]

  • 14. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
    Lacave R, Coulet F, Ricci S, Touboul E, Flahault A, Rateau JG, Cesari D, Lefranc JP, Bernaudin JF.
    Br J Cancer; 1998 Mar 01; 77(5):694-702. PubMed ID: 9514046
    [Abstract] [Full Text] [Related]

  • 15. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.
    Toxicol In Vitro; 2010 Sep 01; 24(6):1474-81. PubMed ID: 20656007
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.
    Li T, Kong AN, Ma Z, Liu H, Liu P, Xiao Y, Jiang X, Wang L.
    Oncotarget; 2016 Apr 12; 7(15):20236-48. PubMed ID: 26934120
    [Abstract] [Full Text] [Related]

  • 19. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
    Gonzalez Manzano R, Versanvoort C, Wright K, Twentyman PR.
    Eur J Cancer; 1996 Nov 12; 32A(12):2136-41. PubMed ID: 9014757
    [Abstract] [Full Text] [Related]

  • 20. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.
    Cell Biochem Biophys; 2009 Nov 12; 55(2):95-105. PubMed ID: 19593673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.